
Laboratory
Prove it first. Then promise it.
Our own laboratory in Saint Petersburg. Formulas are created here, active ingredients are checked, and textures are worked out — before a product goes into production.
2024
patent on our own biocomplex
2026
participant of the Skolkovo project
St. Petersburg
our own laboratory
01
We study the actives
For a care task we choose ingredients that already have data: how they behave in a formula, and what they are compatible with.
02
We build the formula
In the laboratory in Saint Petersburg we build the composition, the texture, and the stability. The 2024 patent protects the almea DR-DHQ-1 complex — encapsulated dihydroquercetin that stays stable in the formula longer.
03
We test stability
We test how the formula holds its texture and the properties we will print on the pack. The source for each of those properties sits in the evidence base.
04
We control the batch
Raw materials are checked on the way in. Every batch at the Saint Petersburg site is checked before it ships.
05
Open sources
The patent, Skolkovo status, a scientific publication, and the clinical assessment of XLASH serums are gathered in the evidence base, with a date and a link.
06
Skolkovo, 2026
Since 2026, ООО «АЛМЕА» has been a participant of the Skolkovo project, registry entry No. 112898. The status was granted for the company’s own technologies.